Research, partnerships and case studies
.jpeg)








Solu to Enable a Cedars-Sinai Medical Center Research Study on Epidemiological and Antibiotic Resistance of Hospital Infections with Genomics
Cedars-Sinai Medical Center and health technology company Solu announce today a partnership to study and understand hospital-acquired infections from an epidemiological and antibiotic resistance perspective. Solu offers an end-to-end service that provides insight into the causes of antibiotic resistance and whether the infection is hospital-acquired.